Analyst Ratings January 28, 2026

Evercore ISI Keeps F5 Networks at In Line, $320 Target After Strong Quarter

Robust Systems growth and early AI wins underpin upgraded guidance, while memory-cost pressure clouds second-half gross margins

By Sofia Navarro FFIV
Evercore ISI Keeps F5 Networks at In Line, $320 Target After Strong Quarter
FFIV

Evercore ISI maintained an In Line rating and a $320 price target on F5 Networks following a December-quarter beat on both revenue and EPS. The company reported $822 million in revenue and $4.45 in EPS, outpacing multiple analyst forecasts. Strong Systems sales and emerging enterprise AI deployments helped lift results and prompted management to raise fiscal 2026 guidance, even as the company flagged a modest gross-margin headwind from higher memory costs later in the year.

Key Points

  • F5 reported $822 million in revenue and $4.45 EPS for the December quarter, surpassing multiple analyst expectations; Systems grew 37%, Services 4%, and Software declined 8%. - Markets affected: Networking, Enterprise Software, Cloud/Infrastructure.
  • Management signaled accelerating enterprise AI adoption with Q1 AI-related wins matching fiscal 2025 totals and direct AI revenue rising to low double-digit millions, supporting management’s decision to raise fiscal 2026 guidance. - Markets affected: AI, Data Delivery, Cybersecurity.
  • Company guidance was raised to 5-6% sales growth for fiscal 2026 and EPS to $15.85, while several analysts lifted price targets (RBC to $345, Piper Sandler to $325, Evercore ISI at $320). - Markets affected: Equity analysts, Institutional investors.

Overview

Evercore ISI left F5 Networks (NASDAQ:FFIV) at an In Line rating and maintained a $320 price target after the company reported December-quarter results that topped most expectations. Trading near $287.24 at the time of the report, F5 is flagged as slightly undervalued per InvestingPro Fair Value estimates and carries an overall financial health rating of "GREAT."

Quarterly results in detail

F5 recorded $822 million in revenue and $4.45 in earnings per share for the December quarter. Those results exceeded analyst projections cited in different reports - one set of expectations placed revenue at roughly $758 million with EPS forecast at $3.66, while other market estimates referenced $755.96 million in revenue and $3.65 in EPS. The company’s Systems segment posted impressive growth of 37%, Services rose 4%, and Software declined 8% year-over-year.

InvestingPro data included in the reporting highlights an 81.4% gross profit margin and a price-to-earnings ratio of 24.4 for F5. Later margin metrics reported for the period showed gross margins at 83.8%, largely flat on a year-over-year basis, and operating margins that expanded by 80 basis points to 38.2%.

AI traction and revenue mix

Management emphasized a notable inflection in enterprise AI adoption. New AI-related customer wins in the first quarter matched the total for all of fiscal 2025. Revenue attributable to direct AI use cases rose to the low double-digit millions from prior single-digit millions, and the company described the mix of AI-related revenue as balanced between data delivery and AI runtime security. InvestingPro noted that this AI momentum is a contributor to F5’s 8.8% revenue growth over the last twelve months.

Geographic performance and margin outlook

By region, EMEA led with 23% growth, supported by regulatory momentum and data sovereignty mandates. The Americas grew modestly by 2%, while APAC declined 1%. Despite healthy top-line results, F5 warned of a modest headwind to gross margins in the second half of the fiscal year, attributing the pressure primarily to rising memory costs.

Guidance and market reaction

Following the quarter, F5 raised its fiscal 2026 outlook, setting expected sales growth at 5-6% versus analyst forecasts centered on 2%. The company also set FY26 EPS at $15.85 compared with a $15.00 analyst consensus. Market responses included upward revisions to price targets by several firms: RBC Capital increased its target to $345 and Piper Sandler to $325, while Evercore ISI’s maintained $320 target reflects continued confidence in the company’s recent operating momentum.

Balance-sheet profile and valuation context

With a market capitalization near $16.2 billion, F5 is characterized in the InvestingPro analysis as holding more cash than debt on its balance sheet, a point highlighted in the platform’s financial-health metrics. The reported P/E of 24.4 is noted as relatively low when compared to the company’s near-term earnings growth outlook.

Other items

The company reported first-quarter fiscal 2026 results that topped the market and subsequently raised full-year guidance, increasing revenue expectations and boosting EPS guidance by $0.85. The filing and analyst commentary also referenced a security incident that occurred in October 2025; analysts observed the incident had minimal impact on results, a factor that contributed to the generally optimistic reception among analysts.


Note: The article presents reported financial and operational data, analyst reactions, and guidance adjustments as disclosed by the company and cited research services.

Risks

  • Management warned of a modest second-half gross-margin headwind driven primarily by rising memory costs, which could pressure profitability if those costs persist. - Sectors impacted: Hardware vendors, Cloud infrastructure providers.
  • The Software segment declined 8% in the quarter, representing a potential vulnerability in recurring software revenue if the trend continues. - Sectors impacted: Enterprise software and subscription services.
  • A security incident in October 2025 was noted; although analysts cited minimal impact on results, such events remain an operational risk for cybersecurity and enterprise-networking providers. - Sectors impacted: Cybersecurity, Enterprise IT.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026